Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline MAXN Q4 2024 Earnings Significant EPS Beat Amidst Revenue Disclosure Gap KNSA Q1 2026 Earnings EPS Surpasses Estimates by 315 Despite Stock Decline Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher RH Q1 2026 Earnings EPS Misses Estimates Stock Declines Amid Luxury Market Challenges